SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-169955
Filing Date
2021-05-24
Accepted
2021-05-24 07:11:44
Documents
49
Period of Report
2021-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d184327d8k.htm   iXBRL 8-K 84004
2 EX-2.1 d184327dex21.htm EX-2.1 1070674
3 EX-2.2 d184327dex22.htm EX-2.2 43964
4 EX-2.3 d184327dex23.htm EX-2.3 101184
5 EX-10.1 d184327dex101.htm EX-10.1 70264
6 EX-10.2 d184327dex102.htm EX-10.2 75704
7 EX-10.3 d184327dex103.htm EX-10.3 75088
8 EX-10.4 d184327dex104.htm EX-10.4 37842
9 EX-99.1 d184327dex991.htm EX-99.1 432401
10 EX-99.2 d184327dex992.htm EX-99.2 55556
11 EX-99.3 d184327dex993.htm EX-99.3 38799
12 EX-99.4 d184327dex994.htm EX-99.4 19518
16 GRAPHIC g184327dsp0001.jpg GRAPHIC 3229
17 GRAPHIC g184327dsp0001a.jpg GRAPHIC 4055
18 GRAPHIC g184327ex99_3s10g1.jpg GRAPHIC 212598
19 GRAPHIC g184327ex99_3s11g1.jpg GRAPHIC 283460
20 GRAPHIC g184327ex99_3s12g1.jpg GRAPHIC 319990
21 GRAPHIC g184327ex99_3s13g1.jpg GRAPHIC 399775
22 GRAPHIC g184327ex99_3s14g1.jpg GRAPHIC 461894
23 GRAPHIC g184327ex99_3s15g1.jpg GRAPHIC 283612
24 GRAPHIC g184327ex99_3s16g1.jpg GRAPHIC 291989
25 GRAPHIC g184327ex99_3s17g1.jpg GRAPHIC 326423
26 GRAPHIC g184327ex99_3s18g1.jpg GRAPHIC 499606
27 GRAPHIC g184327ex99_3s19g1.jpg GRAPHIC 181583
28 GRAPHIC g184327ex99_3s1g1.jpg GRAPHIC 140744
29 GRAPHIC g184327ex99_3s20g1.jpg GRAPHIC 76013
30 GRAPHIC g184327ex99_3s2g1.jpg GRAPHIC 636032
31 GRAPHIC g184327ex99_3s3g1.jpg GRAPHIC 1003221
32 GRAPHIC g184327ex99_3s4g1.jpg GRAPHIC 392291
33 GRAPHIC g184327ex99_3s5g1.jpg GRAPHIC 112249
34 GRAPHIC g184327ex99_3s6g1.jpg GRAPHIC 669154
35 GRAPHIC g184327ex99_3s7g1.jpg GRAPHIC 436340
36 GRAPHIC g184327ex99_3s8g1.jpg GRAPHIC 389802
37 GRAPHIC g184327ex99_3s9g1.jpg GRAPHIC 378817
38 GRAPHIC g184327g0522101546836.jpg GRAPHIC 2253
39 GRAPHIC g184327g0524000659125.jpg GRAPHIC 7063
40 GRAPHIC g184327g0524000659359.jpg GRAPHIC 4147
41 GRAPHIC g184327page001.jpg GRAPHIC 230060
  Complete submission text file 0001193125-21-169955.txt   13365692

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA xers-20210524.xsd EX-101.SCH 3078
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE xers-20210524_lab.xml EX-101.LAB 18887
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xers-20210524_pre.xml EX-101.PRE 11865
42 EXTRACTED XBRL INSTANCE DOCUMENT d184327d8k_htm.xml XML 3528
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 21951063
SIC: 2834 Pharmaceutical Preparations